News

Enzymatica shares jump as company says mouth spray can deactivate COVID-19 – MarketWatch


Shares of Enzymatica
ENZY,
+72.59%
jumped 67% in Stockholm as the company said preliminary results show the ability of the mouth spray ColdZyme, in vitro, to deactivate SARS-CoV-2, the virus causing the COVID-19 pandemic. The study demonstrated that ColdZyme deactivates SARS-CoV-2 coronavirus by 98.3%, the company said. “Even if the current in vitro results cannot be directly translated into clinical efficacy, it is very interesting that ColdZyme is able to effectively deactivate SARS-CoV-2 in vitro since it constitutes a proof-of-principle that can be taken further into clinical studies. Thus, the results indicate that ColdZyme can offer a protective barrier against SARS-CoV-2,” says Claus Egstrand, Enzymatica’s chief operating officer.

Source : https://www.marketwatch.com/story/enzymatica-shares-jump-as-company-says-mouth-spray-can-deactivate-covid-19-2020-07-20

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button